Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Kyowa Hakko Kirin and Cephalon begin clinical testing of CEP-37250

Nov. 14, 2011

Celldex Therapeutics begins phase I trial of CDX-1127

Nov. 10, 2011

LivTech and Yakult Honsha enter option agreement for LIV-2008 anticancer program

Nov. 9, 2011

Atlab Pharma and BZL Biologics enter licensing agreement for [177Lu]-J591

Nov. 4, 2011

Immunomedics resumes clivatuzumab tetraxetan study

Nov. 3, 2011

AgonOx and MedImmune join to develop TNF receptor superfamily member 4 agonists

Nov. 3, 2011

FDA grants new orphan drug status to BioVaxID

Oct. 31, 2011

Seattle Genetics starts new Adcetris trial in nonlymphoma malignancies

Oct. 26, 2011

Studies confirm efficacy of Transcend-trastuzumab conjugate in HER2-positive breast cancer

Oct. 19, 2011

OTSA-101 clear to enter clinic in France

Oct. 18, 2011

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...